A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug

Abdulaziz A.M. Abahussain, S. Z.J. Zaidi*, M. H. Nazir, M. Raza, M. H. Nazir, S. Hassan

*Awdur cyfatebol y gwaith hwn

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

Crynodeb

Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.

Iaith wreiddiolSaesneg
Tudalennau (o-i)234-239
Nifer y tudalennau6
CyfnodolynJournal of New Materials for Electrochemical Systems
Cyfrol25
Rhif cyhoeddi4
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 31 Rhag 2022

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn